Urinary oxalic acid excretion was determined in 21 healthy people and 70 patients with renal stones. In the group of 31 patients with calcium oxalate-containing renal stones the mean value of urinary oxalate exretion was significantly higher than both in the normals and the patients with non-oxalate renal stones. Urinary oxalate excretion above the upper limit was found in 12 patients with calcium oxalate-containing renal stones (38.7%) and in one patient with radio-paque renal stones and nephrocalcinosis. In the patients with hyperoxaluria great variability in oxalate excretion was found. There was no relationship between urinary oxalate and calcium excretion and between urinary oxalate excretion and 24-hour volume of urine. It is suggested that there is relationship between the increased urinary oxalate excretion and recurrent calcium oxalate-containing renal stones formation in the investigated group of patients.

Keywords:
Calcium oxalate containing renal stones, Radio-opaque renal stones, Hyperoxaluria, Intermittent hyperoxaluria, Hypercalciuria
This content is only available via PDF.
© 1971 S. Karger AG, Basel
1971
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.